About: Prospects for Tuberculosis Elimination

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Prospects for Tuberculosis Elimination Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article (publication date: 18 March 2013)

Attributes	Values
rdf:type	Item
description	artículu científicu espublizáu en 2013 (ast) наукова стаття, опублікована в березні 2013 (uk) 2013 թուականի Մարտին հրատարակուած գիտական յօդուած (hyw) 2013 թվականի մարտին հրատարակված գիտական հոդված (hy) wetenschappelijk artikel (gepubliceerd op 2013/03/18) (nl) مقالة علمية (نشرت في 18-3-2013) (ar) im März 2013 veröffentlichter wissenschaftlicher Artikel (de) scientific article (publication date: 18 March 2013) (en)
publication date	wds:Q29392153-DC9BE3A1-F2DD-4CD9-BA6F-0D42E926A2FC
publication date	2013-03-18 00:00:00Z (xsd:dateTime)
author name string	wds:Q29392153-438B25C2-06D1-4F4C-A135-B18EB50693E4
OpenCitations bibliographic resource ID	wds:Q29392153-F7178FC7-7CBA-4122-A8A3-54A19CEA4E30
OpenCitations bibliographic resource ID	https://w3id.org/oc/corpus/br/1891121
author name string	Katherine Floyd
OpenCitations bibliographic resource ID	1891121
rdfs:label	Prospects for Tuberculosis Elimination (en) Prospects for Tuberculosis Elimination (ast)
skos:prefLabel	Prospects for Tuberculosis Elimination (en) Prospects for Tuberculosis Elimination (ast)
name	Prospects for Tuberculosis Elimination (en) Prospects for Tuberculosis Elimination (ast)
author	wds:Q29392153-17D78F13-3AE8-4A4C-B430-9F1E34B0E368 wds:Q29392153-2709122C-1C9E-48EC-86EA-75BA62BF2711 wds:Q29392153-B2C0AC04-F931-4441-A3A1-6C769FCBC402
author	Mario Raviglione Christopher Dye Philippe Glaziou
title	wds:Q29392153-055EF21F-BAAB-4052-BC9E-C68C1761C1DA
title	Prospects for Tuberculosis Elimination (en)
page(s)	wds:Q29392153-23F434F5-6054-4CA1-B3FE-D6BDD4D003D5
page(s)	271-286
instance of	wds:Q29392153-45dd68e0-e412-4832-8141-503ca05ce700 wds:Q29392153-ED38D7A8-6DC4-46E2-A322-07AA83AF0872
instance of	review article scholarly article
main subject	wds:Q29392153-8B810FA4-CB89-4F1A-8E72-0B43C8D053DC
main subject	tuberculosis
PubMed ID	wds:Q29392153-18B35060-BCEE-4FE9-95F1-2BA25B880EC5
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/23244049
PubMed ID	23244049
published in	wds:Q29392153-8ADB9188-5711-498D-9B69-0A1D910C0006
published in	Annual Review of Public Health
issue	wds:Q29392153-297E68A8-06A4-4FA0-BD1D-578D6B67832E
volume	wds:Q29392153-C3377B6F-6E5F-41B2-BBA2-AA9D80F9350B
issue	1
volume	34
DOI	wds:Q29392153-0B3AF7FE-ADEE-4E36-9B58-1B459E00D79E
DOI	http://dx.doi.org/10.1146/ANNUREV-PUBLHEALTH-031912-114431
DOI	10.1146/ANNUREV-PUBLHEALTH-031912-114431
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q29392153
is cites work of	Bridging the gap between evidence and policy for infectious diseases: How models can aid public health decision-making The role of B cells and humoral immunity in Mycobacterium tuberculosis infection Timing of tuberculosis transmission and the impact of household contact tracing. An agent-based simulation model First-in-human trial of the post-exposure tuberculosis vaccine H56:IC31 in Mycobacterium tuberculosis infected and non-infected healthy adults Immune requirements for protective Th17 recall responses to Mycobacterium tuberculosis challenge. Isoniazid preventive treatment among child contacts of adults with smear-positive tuberculosis in The Gambia Antibodies and tuberculosis Neither primary nor memory immunity to Mycobacterium tuberculosis infection is compromised in mice with chronic enteric helminth infection Vaccines against tuberculosis: moving forward with new concepts After 2015: infectious diseases in a new era of health and development Diabetes and immunity to tuberculosis Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Global epidemiology of tuberculosis. The ongoing challenge of latent tuberculosis Limited activity of clofazimine as a single drug in a mouse model of tuberculosis exhibiting caseous necrotic granulomas TLR2-targeted secreted proteins from Mycobacterium tuberculosis are protective as powdered pulmonary vaccines. Impact and cost-effectiveness of new tuberculosis vaccines in low- and middle-income countries A review of clinical models for the evaluation of human TB vaccines TB or not TB: that is no longer the question Tuberculosis control in China: use of modelling to develop targets and policies Global burden of drug-resistant tuberculosis in children: a mathematical modelling study A Collaborative Approach for "ReSeq-ing" Mycobacterium tuberculosis Drug Resistance: Convergence for Drug and Diagnostic Developers Tuberculosis Control of Mycobacterial Infections in Mice Expressing Human Tumor Necrosis Factor (TNF) but Not Mouse TNF. How much is tuberculosis screening worth? Estimating the value of active case finding for tuberculosis in South Africa, China, and India (Not) measuring in the dark Safety and immunogenicity of candidate vaccine M72/AS01E in adolescents in a TB endemic setting The novel tuberculosis vaccine, AERAS-402, is safe in healthy infants previously vaccinated with BCG, and induces dose-dependent CD4 and CD8T cell responses Modeling the potential impact of host population survival on the evolution of M. tuberculosis latency Interleukin 27R regulates CD4+ T cell phenotype and impacts protective immunity during Mycobacterium tuberculosis infection Helminth-induced arginase-1 exacerbates lung inflammation and disease severity in tuberculosis Tuberculosis Infection in the United States: Prevalence Estimates from the National Health and Nutrition Examination Survey, 2011-2012 Effect of isoniazid on antigen-specific interferon-γ secretion in latent tuberculosis Feasibility of achieving the 2025 WHO global tuberculosis targets in South Africa, China, and India: a combined analysis of 11 mathematical models. Heterologous boosting with recombinant VSV-846 in BCG-primed mice confers improved protection against Mycobacterium infection Molecular profiling of Mycobacterium tuberculosis identifies tuberculosinyl nucleoside products of the virulence-associated enzyme Rv3378c Adenovirally-Induced Polyfunctional T Cells Do Not Necessarily Recognize the Infected Target: Lessons from a Phase I Trial of the AERAS-402 Vaccine A double-blind, randomised, placebo-controlled, dose-finding trial of the novel tuberculosis vaccine AERAS-402, an adenovirus-vectored fusion protein, in healthy, BCG-vaccinated infants. Comparison of trends in tuberculosis incidence among adults living with HIV and adults without HIV--Kenya, 1998-2012 Developing whole mycobacteria cell vaccines for tuberculosis: Workshop proceedings, Max Planck Institute for Infection Biology, Berlin, Germany, July 9, 2014. Controlling the seedbeds of tuberculosis: diagnosis and treatment of tuberculosis infection Transforming the fight against tuberculosis: targeting catalysts of transmission. Self-administered treatment for tuberculosis among pastoralists in rural Ethiopia: how well does it work? Chemokines in tuberculosis: the good, the bad and the ugly How can mathematical models advance tuberculosis control in high HIV prevalence settings? Phylogenetic analysis of vitamin B12-related metabolism in Mycobacterium tuberculosis. Falling Short of the Rights to Health and Scientific Progress: Inadequate TB Drug Research and Access Three months of weekly rifapentine and isoniazid for treatment of Mycobacterium tuberculosis infection in HIV-coinfected persons Qualification of a whole blood intracellular cytokine staining assay to measure mycobacteria-specific CD4 and CD8 T cell immunity by flow cytometry

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software